Congress Sent Tick Disease Funding Bill to President
The legislation extends federal support for tick-borne disease research and surveillance through 2030.
Updated on Sept. 30, 2026 in COVID-19
Live Poll
Should the federal government continue funding specialized programs for tick-borne disease research?
Congress has presented the Kay Hagan Tick Reauthorization Act to President Donald Trump for his signature. The bill aims to restore federal funding authority for vital research and state-level tick-borne disease programs.
Why it matters
The legislation ensures continued federal resources for identifying and managing the spread of tick-borne illnesses across the country. It addresses a lapse in funding authority that occurred when the previous authorization expired in 2025.
The bill represents a renewal of the original 2019 act that governs national tick-borne disease strategies. It seeks to extend funding authority through fiscal 2030, following the expiration of the prior authorization on September 30, 2025.
The players
Donald Trump
He is the current President of the United States who must now decide whether to sign or veto the legislation.
The details
The reauthorization package successfully passed through both chambers of Congress before arriving at the White House. Under federal procedure, the President has 10 days, excluding Sundays, to sign the bill into law or issue a veto.
Timeline
The original Kay Hagan Tick Act was enacted in 2019.
Previous funding authorization for the programs expired on September 30, 2025.
Congress presented the reauthorization bill to President Donald Trump on September 30, 2026.
The bill will automatically become law on October 10, 2026, if the President takes no action.
The Big Picture
This legislation serves as the direct legislative extension of the 2019 Kay Hagan Tick Act. The current renewal maintains the federal infrastructure established by the original policy to combat vector-borne health threats.
The renewal of this act ensures that states retain the federal resources necessary to monitor and combat tick-borne disease outbreaks. Residents in areas with high tick activity will see continued public health surveillance and prevention strategies supported by federal grants.
The takeaway
This legislation provides long-term stability for public health programs tasked with managing vector-borne risks through 2030. Maintaining these programs is essential for regional health departments to keep pace with evolving disease transmission patterns.
Further reading
For broader context on public health disease management, explore our COVID-19 section.
Live Poll
Should the federal government continue funding specialized programs for tick-borne disease research?
